Lixisenatide Reduces Motor Disability Progression in Parkinson Disease

THURSDAY, April 4, 2024 -- For patients with Parkinson disease, lixisenatide yields less progression of motor disability than placebo, according to a study published in the April 4 issue of the New England Journal of Medicine. Wassilios G....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news